Stock News on Early Hour Stocks Movers (Shanda Games, FUQI, Geron Corporation, QCOR)

Shanda Games Limited(ADR) (NASDAQ:GAME) fell over 4.70% after its second-quarter net income dropped to 304.3 million RMB ($44.8 million), or 1.06 RMB (16 cents) per American depositary shares, from 363.2 million RMB, or 1.32 RMB per ADS, in the prior-year quarter. Revenue dropped 4 percent to 1.11 billion RMB ($163.9 million) from 1.16 billion RMB. Analysts, on average, expected the company to report earnings of 16 cents per share on revenue of $166.40 million.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

Shanda Games Limited (Shanda Games) is an online game company. Shanda Games develops and sources an array of game content through multiple channels, including in-house development, licensing, investment and acquisition, co-development and co-operation.

Fuqi International, Inc. (NASDAQ:FUQI) plunged 23% to $4.91 after the company said that it was asked by the SEC of a formal investigation, and has received a subpoena from the SEC for certain documents, regarding its failure to timely file required periodic reports, as well as other matters.

Fuqi International, Inc. (Fuqi) is a designer of precious metal jewelry in China, developing, promoting, and selling a range of products in the Chinese luxury goods market.

Geron Corporation (NASDAQ:GERN)  is in collaboration with Sierra Sciences, TA Sciences, PhysioAge, and the Spanish National Cancer Research Center, announced the first compound ever discovered that activates the enzyme telomerase in the human body - a critical prerequisite for technology that could arrest or reverse the aging process in humans. This compound is a natural product derived nutraceutical known as TA-65. Shares of Geron Corp. surged more than 6% in evening trading.

Geron Corporation (Geron) is a biopharmaceutical company that is developing biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes.

You can Subscribe to these Free Stock Alerts by visiting:  http://www.PennyStockPickReport.com

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) fell 4% to $9.98 after it announced that the U.S. Food and Drug Administration (FDA) has informed Questcor that the FDA will require additional time beyond the current action date of September 11, 2010 to complete its review of Questcor's supplemental new drug application (sNDA) for H.P. Acthar Gel (repository corticotropin injection) in the treatment of infantile spasms.

Questcor Pharmaceuticals, Inc. (Questcor) is a pharmaceutical company focused on diseases and disorders. Questcor’s primary drug is H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved by the United States Food and Drug Administration (FDA) for the treatment of a variety of diseases and disorders.

About http://www.PennyStockPickReport.com

Penny Stock Pick Report offers stock news on OTC, PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers receive daily up to date stock information on hot stocks, most active movers, top gainers, penny stocks and much more. If you wish to feature your organization on our website then you can contact us at the email given below.